NKGen Biotech, Inc. financial data

Location
Santa Ana, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2024 - 08 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.38 % -76.4%
Debt-to-equity -126 % +5.64%
Return On Equity 73.3 % -74.1%
Return On Assets -280 % -137%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 124M shares +252%
Common Stock, Shares, Outstanding 44.2M shares +102%
Entity Public Float 13.7M USD
Common Stock, Value, Issued 4K USD +100%
Weighted Average Number of Shares Outstanding, Basic 28.8M shares +86.9%
Weighted Average Number of Shares Outstanding, Diluted 28.8M shares +86.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Cost of Revenue 0 USD
Research and Development Expense 10.7M USD -32%
General and Administrative Expense 16.3M USD +15.9%
Costs and Expenses 27M USD -9.35%
Operating Income (Loss) -27M USD +9.35%
Nonoperating Income (Expense) 5.95M USD -40.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -80M USD -116%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -44.3M USD +46.6%
Earnings Per Share, Basic -1 USD/shares +71.4%
Earnings Per Share, Diluted -1 USD/shares +71.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 106K USD +308%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 0 USD
Assets, Current 2.46M USD +27.4%
Property, Plant and Equipment, Net 13.3M USD -8.04%
Operating Lease, Right-of-Use Asset 379K USD
Assets 16.2M USD -1.52%
Accounts Payable, Current 14.4M USD +30.4%
Employee-related Liabilities, Current 640K USD -29.7%
Accrued Liabilities, Current 460K USD -66.2%
Liabilities, Current 58M USD +46.9%
Deferred Income Tax Liabilities, Net 8K USD -75.8%
Operating Lease, Liability, Noncurrent 246K USD
Liabilities 86.1M USD +14.6%
Retained Earnings (Accumulated Deficit) -206M USD -27.3%
Stockholders' Equity Attributable to Parent -69.9M USD -19.1%
Liabilities and Equity 16.2M USD -1.52%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.03M USD +17.9%
Net Cash Provided by (Used in) Financing Activities 4.01M USD -27.9%
Net Cash Provided by (Used in) Investing Activities 35K USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 44.2M shares +102%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8K USD -98.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 235K USD -14.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 120K USD
Deferred Tax Assets, Valuation Allowance 39.8M USD +18%
Deferred Tax Assets, Gross 40.1M USD +17.5%
Operating Lease, Liability 400K USD
Depreciation 1.2M USD +9.09%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -48.5M USD
Lessee, Operating Lease, Liability, to be Paid 491K USD -32.4%
Property, Plant and Equipment, Gross 18.2M USD -0.47%
Operating Lease, Liability, Current 154K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 249K USD +2.89%
Lessee, Operating Lease, Liability, to be Paid, Year One 242K USD +2.98%
Operating Lease, Weighted Average Discount Rate, Percent 0.22 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 91K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 249K USD
Deferred Tax Assets, Operating Loss Carryforwards 29.1M USD +27.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.8M USD +408%
Additional Paid in Capital 137M USD +12.3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 295K USD -2.96%
Deferred Tax Assets, Net of Valuation Allowance 299K USD -19.8%
Share-based Payment Arrangement, Expense 4.14M USD +0.17%
Interest Expense 1.07M USD +3044%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%